Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

News

News and Press Releases:

A scanning electron microscope image showing a single red-stained T cell infected by numerous mustard-colored HIV particles adhering to its surface.
© NIAID

HIV’s genetic remnants are not as silent as they seem

Tubercle bacilli
© cdc/James Archer

25 years of TB genomics in Hamburg: Migration increases pathogen diversity, but local strains drive transmission

Migration has increased the genetic diversity of TB bacteria in Hamburg. Local transmission, however, has continued to be driven mainly by established strains. These findings are revealed in a long
The pathogen Clostridioides difficile
© CDC/Medical Illustrator: Jennifer Oosthuizen

Well-Known Natural Compound Shows Unexpected Effect Against a Dreaded Pathogen

Treatment with broad-spectrum antibiotics often leads to side effects, as it affects not only the pathogens but also the “good” bacteria in the gut. A research team from Hannover Medical School (MHH)
Portrait photos of Maura Dandri and Yazdan Yazdanpanah
© UKE/Eva Hecht, ANRS MIE/Sébastien Delarque

Joint call for proposals between ANRS MIE and DZIF on HIV, hepatitis B, and hepatitis Delta cure

Key points The French National Research Agency for HIV, Viral Hepatitis and Emerging Infectious Diseases (ANRS MIE) and the German Center for Infection Research (DZIF) are launching a joint call for
A gloved hand holds a vaccine vial labeled “Ervebo_solution for injection_rVSVΔG-ZEBOV-GP_live_1 dose”
© Deutsches Museum/Alexander Goettert

Ebola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans

The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate
All news

Call for applications: DZIF Rising Star Award

Apply now!

The DZIF Rising Star Award honors early-career DZIF scientists for outstanding scientific achievements in translational infection research. The award includes a cash prize of €2,500. Submit your application to the DZIF Academy until October 31, 2026.

More info on how to apply
Scientists and the text DZIF Rising Star Award Apply now until October 31, 2026!
© DZIF/flyingbrainsproductions

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Diese Sicherheitsfrage überprüft, ob Sie ein menschlicher Besucher sind und verhindert automatisches Spamming.

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. By [...]

Read more
Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center (ClinTB)

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, researchers develop genetically engineered phage lysins and specific bacteriocins to eliminate healthcare-associated pathogens such as Staphylococcus aureus. They investigate their mechanisms of action and potential mechanisms of resistance. They also compare broad-spectrum and narrowly targeted agents to determine which are more effective at reducing nasal colonization [...]

Read more

Our Partner Sites

Location

Hannover - Braunschweig

Research areas
Contact person
Silke Hartmann

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover-Braunschweig
Project Manager "Community-Acquired Infections at Mucosal Interfaces"
E-Mail Send mail
More about this location
Location

Heidelberg

Research areas
Contact person
More about this location
Location

Bonn - Köln

Research areas
Contact person
Prof Achim Hörauf: Coordinator of the consortium "Neglected tropical diseases" at DZIF.

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator "Malaria and Neglected Tropical Diseases"
E-Mail Send mail
More about this location
Location

Hamburg - Lübeck - Borstel - Riems

Research areas
Contact person
Nicole Fischer

Prof. Dr. Nicole Fischer

University Medical Center Hamburg-Eppendorf
Deputy Partner Site Speaker Hamburg-Lübeck-Borstel-Riems
Coordinator Bridging Topic "Diagnostics"
E-Mail Send mail
More about this location
München Tübingen Heidelberg Gießen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems